Keiretsu Capital β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
Cloud ComputingCybersecurityEnterprise SoftwareFintechSaaSBoulder, US
Co-investorsNext Frontier CapitalTechstarsRockies Venture Club
Blaze Bioscience develops peptide-based fluorescent imaging agents and imaging systems that give surgeons real-time visualization of tumor tissue during cancer surgery.
BiotechHealthtechMedical DevicesSeattle, US
James M. Olson(Director)Steven R. Daly(Executive Officer, Director)inLudmila R. Lobanova(Executive Officer)Julia Novak(Executive Officer)Heather L. Franklin(Director)Dennis M Miller(Executive Officer)
Co-investorsKeiretsu Forum
CurvaFix develops the CurvaFix Low Profile intramedullary nailing system, curved implants for surgical stabilization of pelvic fractures.
HardwareHealthtechMedical DevicesBellevue, US
Jeffrey Poole(Executive Officer)Mark Foster(Executive Officer, Director)inSteven Dimmer(Executive Officer, Director, Promoter)Dong-Gun Kim(Director)
BoardEric Fritz(Director)inJack Tanaka(Director)in
Co-investorsAlliance of AngelsRockies Venture ClubSPRINGROCK VENTURESSwan Venture FundMVM Life Science PartnersSectoral Asset Management+1 more
INDIGO Biosciences is a life sciences company led by professionals with expertise in life sciences, business management, and operations.
AI & Machine LearningBiotechDeep TechMedical DevicesState College, US
Dr. Jack Vanden Heuvel(Chief Scientific Officer, Co-founder)inDr. Blake Peterson(Co-founder)Fred Marroni(President & Chief Executive Officer)in
Co-investorsBroad Street AngelsiNetworksLife Sciences Greenhouse Investments
LumiThera develops the Valeda Light Delivery System, an FDA-authorized photobiomodulation (PBM) device that applies multiple light wavelengths to treat early and intermediate dry age-related macular degeneration (AMD).
BiotechHealthtechMedical DevicesPoulsbo, US
Tracy Puckett(Executive Officer)Clark Tedford(Executive Officer, Director)inScott Bradley(Executive Officer)inDuane Morrison(Executive Officer)inCindy Croissant(Executive Officer)Ryan Montecucco(Executive Officer)
Co-investors3E Bioventures CapitalLife Sciences Greenhouse InvestmentsImagine Ventures
OtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type.
AI & Machine LearningDigital HealthHardwareHealthtechMedical DevicesSeattle, US
Caitlin Cameron(Chair & CEO)in
Co-investorsGolden SeedsDellin InvestmentsFarvatn VentureKeiretsu ForumMindshift CapitalPortfolia+3 more
Albany, US
Carlo Morgantini(Executive Officer, Director)Benjamin Cooley(Director and Chief Executive Officer of the Issuer.)
Co-investorsKeiretsu Forum
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Embera NeuroTherapeuticsEternaTearOtoNexus Medical TechnologiesTextile-Based DeliveryVoyager Pacific Capital Management
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.